ClinConnect ClinConnect Logo
Search / Trial NCT03126396

Assessment of Efficacy & Tolerance of Urgo 310 3166 Dressing in Local Venous or Mixed Leg Ulcers

Launched by LABORATOIRES URGO · Apr 21, 2017

Trial Information

Current as of August 02, 2025

Completed

Keywords

ClinConnect Summary

Assessment of efficacy, tolerance and acceptability of Urgo 310 3166 dressing in the treatment of local venous or mixed leg ulcers: multicenter trial, conducted in France.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Male or female over 18 years old who has provided his/her written informed consent
  • 2. Patient who can be monitored by the same investigation team throughout the whole duration of the study
  • 3. Patient who agrees to wear an effective venous compression system every day, associated with the trial dressing
  • 4. Leg ulcer with an Ankle Brachial Pressure Index (ABPI) not less than 0.7 and not more than 1.3
  • 5. Ulcer area between 3 and 20 cm2
  • 6. Ulcer duration between 3 and 18 months,
  • 7. Ulcer presenting a surface wound bed covered with 50% or more by granulation tissue
  • 8. Moderately or heavily exudative ulcers.
  • Exclusion Criteria:
  • A. Clinical infection on the wound bed.

About Laboratoires Urgo

Laboratoires Urgo is a leading global healthcare company specializing in innovative wound care and advanced therapeutic solutions. With a commitment to enhancing patient outcomes, the company leverages cutting-edge research and development to create high-quality products that address a wide range of medical needs. Laboratoires Urgo's clinical trial initiatives focus on evaluating the efficacy and safety of its offerings, ensuring that they meet the highest standards of care. By fostering partnerships with healthcare professionals and institutions, Laboratoires Urgo aims to contribute to the advancement of medical science and improve the quality of life for patients worldwide.

Locations

Chenôve, , France

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials